Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Dustin T. Smith, MD

  • News

    How Can Tumor Lysis Syndrome Be Prevented and Managed in Cancer Patients?

    July 1, 2013

    Preventative measures include starting IVF prior to cancer treatment, administering allopurinol and/or rasburicase to patients at risk

  • News

    Southern Hospital Medicine Conference Drives Home the Value of Hospitalists

    February 2, 2013

    Hospital medicine leaders discuss the need to develop standardized processes among clinicians to reduce errors, lower costs of hospitalized patient care

  • News

    ITL: Physician Reviews of HM-Relevant Research

    September 8, 2012

    Drotrecogin alfa (activated) does not decrease mortality in patients with septic shock

  • News

    ITL: Physician Reviews of HM-Relevant Research

    September 5, 2012

    Drotrecogin alfa (activated) does not decrease mortality in patients with septic shock

  • News

    ITL: Physician Reviews of HM-Relevant Research

    August 29, 2012

    Warfarin vs. aspirin in heart-failure patients; aspirin after anticoagulation prevents VTE recurrence; novel oral anticoagulants vs. warfarin in afib patients; intravenous metronidazole for mild C. diff infection; frequency of Foley catheter complications vs. CAUTI; intensive hyperglycemia control in noncritical hospitalized patients; risk score predicts 30-day mortality after noncardiac surgery; and temperature, white blood cell count are not sensitive predictors of bacteremia.

  • News

    ITL: Physician Reviews of HM-Relevant Research

    August 7, 2012

    Azithromycin associated with a small absolute increase in cardiovascular deaths

  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences